Investigation of the H(+)-myo-inositol transporter (HMIT) as a neuronal regulator of phosphoinositide signalling

Biochem Soc Trans. 2009 Oct;37(Pt 5):1139-43. doi: 10.1042/BST0371139.

Abstract

Phosphoinositide signalling regulates a series of important neuronal processes that are thought to be altered in mood disorders. Furthermore, mood-stabilizing drugs inhibit key enzymes that regulate phosphoinositide production and alter neuronal growth cone morphology in an inositol-reversible manner. Inositol is taken up by neurons from the extracellular fluid, presumably via membrane transporters; it can also be synthesized by the enzyme MIP-synthase (myo-inositol-1-phosphate synthase) and, in addition, it is generated by inositol phospholipid hydrolysis. The neuronal-specific HMIT (H(+)-myo-inositol transporter) represents a potential regulator of inositol signalling in neurons that warrants further investigation.

Publication types

  • Review

MeSH terms

  • Animals
  • Antimanic Agents / pharmacology
  • Brain / metabolism
  • Carbamazepine / pharmacology
  • Glucose Transport Proteins, Facilitative / genetics
  • Glucose Transport Proteins, Facilitative / metabolism*
  • Humans
  • Inositol / metabolism
  • Lithium Compounds / pharmacology
  • Membrane Transport Proteins / metabolism
  • Neurons / cytology
  • Neurons / metabolism
  • Phosphatidylinositols / metabolism*
  • Signal Transduction / physiology*
  • Valproic Acid / pharmacology

Substances

  • Antimanic Agents
  • Glucose Transport Proteins, Facilitative
  • Lithium Compounds
  • Membrane Transport Proteins
  • Phosphatidylinositols
  • SLC2A13 protein, human
  • Carbamazepine
  • Inositol
  • Valproic Acid